Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma

SIMPLE SUMMARY: The EGFR-targeting antibody cetuximab (CTX) combined with radiotherapy has been proven effective for the treatment of locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Due to resistance to CTX, some patients do not benefit from the treatment and recurrence is observe...

Descripción completa

Detalles Bibliográficos
Autores principales: Burgy, Mickaël, Jehl, Aude, Conrad, Ombline, Foppolo, Sophie, Bruban, Véronique, Etienne-Selloum, Nelly, Jung, Alain C., Masson, Murielle, Macabre, Christine, Ledrappier, Sonia, Burckel, Hélène, Mura, Carole, Noël, Georges, Borel, Christian, Fasquelle, François, Onea, Mihaela-Alina, Chenard, Marie-Pierre, Thiéry, Alicia, Dontenwill, Monique, Martin, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235528/
https://www.ncbi.nlm.nih.gov/pubmed/34207120
http://dx.doi.org/10.3390/cancers13123038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235528/
https://www.ncbi.nlm.nih.gov/pubmed/34207120
http://dx.doi.org/10.3390/cancers13123038

Ejemplares similares